"Nearly 90 percent of the $1.1 billion allocated for comparative effectiveness research under the American Recovery and Reinvestment Act will be spent on evidence development and synthesis and on improving research capacity…" - Health Affairs Sunday Health Policy Update - October 17, 2010.
Participate in an interactive discussion with industry experts as they discuss up-to-the-minute happenings on ‘the Hill.’
Topics include:
- Uncover how the $1.1 billion ARRA funds are being disseminated
- Discuss the different types of treatments comparative effectiveness research compare
- Should comparative effectiveness research include measures of cost?
- Will comparative effectiveness research be used to make coverage decisions and recommendations?
- Analyze how CER will save money for the health care system
- View the full agenda here...
Presenters Include:
Constantine A. Gatsonis, PhD
Professor of Medical Science (Biostatistics) and Director
Center for Statistical Sciences, Brown University
David Pizzi
Director, Health Care Policy
Blue Cross and Blue Shield of Florida
View the complete speaker line-up here…
HealthExecWire subscribers SAVE $300 on the current rates!*
~ Early bird discount rate extended! ~
Register by this Friday, December 3rd to receive this discount.
To register, call 800-767-9499 or visit www.worldcongress.com/comparative and
use promo code
AEY396 and priority code HL11007-71708.
(*Not valid for Gov’t rates.)
Strategic Partners
|
To inquire about sponsorship and executive networking opportunities, contact:
Joe Zuccerella
Business Development Manager
The World Congress Leadership Summits
Phone: 781-939-2565
Email: Joseph.Zuccerella@worldcongress.com
|
|